Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

DiaMedica Therapeutics Inc

DMAC
Current price
2.66 USD +0.13 USD (+5.14%)
Last closed 2.59 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 98 300 080 USD
Yield for 12 month +103.05 %
Week
Month
Year
DMAC
21.11.2021 - 28.11.2021

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. The company develops treatments for neurological disorders and cardio-renal disease. Its lead candidate is DM199, a pharmaceutically active recombinant form of the kallikrein-1 protein for the treatment of acute ischemic stroke and other vascular diseases. It is also developing DM300 that is in preclinical stage of development for the treatment of inflammatory diseases. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota. Address: Two Carlson Parkway, Minneapolis, MN, United States, 55447

Analytics

WallStreet Target Price

8.33 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

-5 157 000 USD

Last Quarter

-4 741 000 USD

Key Figures DMAC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -19 364 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -25.47 %
PEG Ratio
Return On Equity TTM -39.62 %
Wall Street Target Price 8.33 USD
Revenue TTM
Book Value 1.47 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -0.6 USD
Diluted Eps TTM -0.6 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics DMAC

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History DMAC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 15.11.2018
Dividend Date 15.11.2018

Stock Valuation DMAC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -2.581
Price Book MRQ 1.7261

Financials DMAC

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators DMAC

For 52 weeks

1.27 USD 4.75 USD
50 Day MA 2.37 USD
Shares Short Prior Month 244 337
200 Day MA 2.54 USD
Short Ratio 4.41
Shares Short 244 175
Short Percent 0.71 %